XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurement (Tables)
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table presents for each of these hierarchy levels, the Company's financial assets and liabilities that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021:
(In thousands)Level ILevel IILevel IIITotal
At March 31, 2022:
Assets
Cash equivalents$45,000 $— $— $45,000 
Marketable securities10,064 — — 10,064 
Foreign currency derivatives— 166 — 166 
Liabilities
Foreign currency derivatives — 5,927 — 5,927 
At December 31, 2021:
Assets
Marketable securities
$5,771 $— $— $5,771 
Foreign currency derivatives
— 196 — 196 
Liabilities
Foreign currency derivatives — 5,911 — 5,911 
Schedule of Carrying Values and Fair Values of the Company's Financial Instruments
The carrying values and estimated fair values of the Company's financial instruments, excluding those that are carried at fair value in the condensed consolidated balance sheets, are summarized as follows:
(In thousands)March 31, 2022
Carrying
Amount
Estimated
Fair Value
Debt instruments:
Term loan A facility$656,806 $659,897 
5.00% Notes due April 2024
397,932 398,500 
4.75% Notes due August 2025
792,603 793,000 
4.25% Notes due February 2029
984,588 915,000 
$2,831,929 $2,766,397 
(In thousands)December 31, 2021
Carrying
Amount
Estimated
Fair Value
Debt instruments:
Term loan A facility$664,581 $670,781 
5.00% Notes due April 2024
397,693 403,500 
4.75% Notes due August 2025
792,098 818,000 
4.25% Notes due February 2029
984,098 997,500 
$2,838,470 $2,889,781